3.81
0.07 (1.87%)
| Penutupan Terdahulu | 3.74 |
| Buka | 3.74 |
| Jumlah Dagangan | 29,427 |
| Purata Dagangan (3B) | 22,853 |
| Modal Pasaran | 35,257,348 |
| Harga / Jualan (P/S) | 17.75 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 16 Sep 2025 - 22 Sep 2025 |
| Margin Operasi (TTM) | -1,264.64% |
| EPS Cair (TTM) | -3.63 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 501.40% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 6,456.94% |
| Nisbah Semasa (MRQ) | 4.81 |
| Aliran Tunai Operasi (OCF TTM) | -17.31 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -11.34 M |
| Pulangan Atas Aset (ROA TTM) | -36.57% |
| Pulangan Atas Ekuiti (ROE TTM) | -1,833.59% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Bercampur |
| Biotechnology (Global) | Bercampur | Bercampur | |
| Stok | Pluri Inc. | Bercampur | - |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -2.5 |
| Purata | -0.67 |
|
Pluri Inc is a biotechnology company, that creates cell-based products for commercial use and is pioneering a biotech revolution that promotes wellbeing and sustainability. The company’s technology platform developed a three-dimensional, or 3D, technology platform for cell expansion with an industrial scale in-house Good Manufacturing Practice, or GMP, cell manufacturing facility. It uses its technology in the field of regenerative medicine, food tech and agricultural technology or agtech. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 43.87% |
| % Dimiliki oleh Institusi | 19.40% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Values First Advisors, Inc. | 30 Sep 2025 | 11,907 |
| Quent Capital, Llc | 30 Sep 2025 | 57 |
| Winch Advisory Services, Llc | 30 Sep 2025 | 26 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 13 Nov 2025 | Pengumuman | Pluri and Subsidiaries Earn Multiple Industry Honors, Named as Overall BioAgriculture Company of the Year |
| 11 Nov 2025 | Pengumuman | Pluri Partners with Miss Universe Skincare Introducing Exosome-Enhanced Regenerative Skincare |
| 10 Nov 2025 | Pengumuman | Leading Global Players Back and Fund Pluri’s Cell-Based Food and Agriculture Collaborations |
| 08 Oct 2025 | Pengumuman | Pluri Subsidiary Coffeesai and Instituto del Café de Chiapas Announce Strategic Collaboration to Advance Cell-Based Coffee Manufacturing in Mexico |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |